Search research articles
Contact Us
Filters
Showing results (71-80 of 84) with videos related to
Page
of 9
Sort By:
Frontiers in Immunology
|
April 11, 2019
Immunometabolic Signatures Predict Risk of Progression to Active Tuberculosis and Disease Outcome
Fergal J Duffy, January Weiner, Scott Hansen, et al.
Frontiers in Immunology
|
May 16, 2020
The Ratiometric Transcript Signature MX2/GPR183 Is Consistently Associated With RTS,S-Mediated Protection Against Controlled Human Malaria Infection
Ying Du, Ethan G Thompson, Julius Muller, et al.
The Journal of Clinical Investigation
|
February 3, 2015
Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling
Kylie M Quinn, Daniel E Zak, Andreia Costa, et al.
Plos Pathogens
|
November 18, 2017
Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease
Thomas J Scriba, Adam Penn-Nicholson, Smitha Shankar, et al.
Frontiers in Microbiology
|
July 13, 2019
Detection of Tuberculosis Recurrence, Diagnosis and Treatment Response by a Blood Transcriptomic Risk Signature in HIV-Infected Persons on Antiretroviral Therapy
Fatoumatta Darboe, Stanley Kimbung Mbandi, Kogieleum Naidoo, et al.
Journal of Virology
|
February 15, 2013
Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus
Andrew S Herbert, Ana I Kuehne, James F Barth, et al.
Nature Communications
|
December 8, 2018
Metabolite changes in blood predict the onset of tuberculosis
January Weiner, Jeroen Maertzdorf, Jayne S Sutherland, et al.
Blood Advances
|
January 4, 2018
Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs
Joseph R Francica, Daniel E Zak, Caitlyn Linde, et al.
Ebiomedicine
|
June 21, 2016
Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial
Daniel F Hoft, Azra Blazevic, Asmir Selimovic, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 5, 2020
Development of an antibody cocktail for treatment of Sudan virus infection
Andrew S Herbert, Jeffery W Froude, Ramon A Ortiz, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 84) with videos related to
Sort By:
Page
of 9
Frontiers in Immunology
|
April 11, 2019
Immunometabolic Signatures Predict Risk of Progression to Active Tuberculosis and Disease Outcome
Fergal J Duffy, January Weiner, Scott Hansen, et al.
Frontiers in Immunology
|
May 16, 2020
The Ratiometric Transcript Signature MX2/GPR183 Is Consistently Associated With RTS,S-Mediated Protection Against Controlled Human Malaria Infection
Ying Du, Ethan G Thompson, Julius Muller, et al.
The Journal of Clinical Investigation
|
February 3, 2015
Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling
Kylie M Quinn, Daniel E Zak, Andreia Costa, et al.
Plos Pathogens
|
November 18, 2017
Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease
Thomas J Scriba, Adam Penn-Nicholson, Smitha Shankar, et al.
Frontiers in Microbiology
|
July 13, 2019
Detection of Tuberculosis Recurrence, Diagnosis and Treatment Response by a Blood Transcriptomic Risk Signature in HIV-Infected Persons on Antiretroviral Therapy
Fatoumatta Darboe, Stanley Kimbung Mbandi, Kogieleum Naidoo, et al.
Journal of Virology
|
February 15, 2013
Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus
Andrew S Herbert, Ana I Kuehne, James F Barth, et al.
Nature Communications
|
December 8, 2018
Metabolite changes in blood predict the onset of tuberculosis
January Weiner, Jeroen Maertzdorf, Jayne S Sutherland, et al.
Blood Advances
|
January 4, 2018
Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs
Joseph R Francica, Daniel E Zak, Caitlyn Linde, et al.
Ebiomedicine
|
June 21, 2016
Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial
Daniel F Hoft, Azra Blazevic, Asmir Selimovic, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 5, 2020
Development of an antibody cocktail for treatment of Sudan virus infection
Andrew S Herbert, Jeffery W Froude, Ramon A Ortiz, et al.
Page
of 9